Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Young TILs Without IL-2 in Metastatic Melanoma
NCT01468818Phase 2Terminated
- Sponsor
- National Cancer Institute
- Start
- Sep 2011
- Primary completion
- Aug 2013
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of young tumor-infiltrating lymphocytes in melanoma, sponsored by National Cancer Institute. Started Sep 2011; status: terminated.
02
Drugs
young tumor-infiltrating lymphocytes
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT01468818.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01468818.